Sorry, we didn't find any business matching “Vision-Integrity-Engineering” in “Garson MB”. We've expanded your search to include associated keywords in hopes of returning listings that may help you.
Vision-Integrity-Engineering near Garson MB
(10 Result(s))
KOHLER Generators & Power Systems
GENERATORS | TRANSFER SWITCHES | SWITCHGEAR | CONTROLS
Winnipeg Kohler Generator Sales. At Pritchard Power Systems our main focus is providing our clients with the best power system solutions, which we have been doing for over half a century in Winnipeg, Ottawa & Toronto. We are a proud distributor of Kohler Generators for the provinces of Saskatchewan, Manitoba & Ontario. Our team of engineers & certified technicians are experienced in all areas of power generation to get the job done right with the least amount of disruption to your family or business.
Like an oil change for your car, planned maintenance programs keep your power systems in top condition and running more efficiently. With Pritchard's qualified factory-trained technicians, we will customize a generator maintenance program for your system so you can maximize your product investment and minimize system downtime.
Fountain Tire in Winnipeg, a leading tire dealer offering car repair services such as oil change, seasonal tire change, mechanical service, etc. We sell Goodyear, Dunlop and Kelly tires for cars, trucks, ATV's, trailers, farm equipment and commercial fleets.
In the modern world, the pace of development is accelerating. The demand for electrical power is growing rapidly as countries around the world develop and strive to improve their standard of living. The rising cost of power also means that developing nati
Structure Monitoring Technology Ltd. or SMT, designs software and electronics used to monitor and evaluate the integrity and performance of commercial and residential buildings. Real-time sensor analysis and remote data collection have allowed Engineers and Researchers to validate designs, materials and methods to produce more efficient & durable buildings, reducing their environmental impact while improving quality assurance throughout the construction and/or restoration process. Founded in 2006, SMT has expanded to include low & high value building projects throughout the world. SMT fosters award winning innovation and scientific excellence in both our product lines and services as well as in our commitment to customers, clients, & researchers.SMT has deployed systems across North America ranging from simple wood frame homes, to glass and steel skyscrapers, shopping centers, heritage buildings, art museums, data centers, and national research labs. The Building Intelligence platform addresses the need for automated remote data collection with analytics of building performance trends/events.
Saving Lives Through Early Disease DiagnosisMiraculins is an emerging biotechnology company committed to extending life, reducing suffering and lowering healthcare costs. Through our leadership in the development and commercialization of diagnostic tests, we strive to improve the overall diagnosis and treatment of patients by enhancing the information available to physicians.The Miraculins AdvantageProducts & ProgramsMiraculins is dedicated to the development and commercialization of diagnostic tests and risk assessment technologies for diseases and conditions that are lacking highly sensitive and specific tests.
Our ProductsAGGRASTAT® - US GP IIb/IIIa inhibitor market - $400 million (AGGRASTAT® + two competitors)TARDOXALTM - in Phase II clinical development for the treatment of Tardive Dyskinesia - a large, unmet needAbout MedicureMedicure is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics.HistoryMedicure founded in 1997 is a specialty pharmaceutical company engaged in the research, clinical development and commercialization of human therapeutics. Medicure has raised over $140 million and focused this investment on the advancement and clinical development of cardiovascular drugs. In 2006 Medicure acquired the USA commercial rights to AGGRASTAT (tirofiban HCl), a cardiovascular drug originally developed by Merck. AGGRASTAT, in combination with heparin, is indicated for the treatment of acute coronary syndrome. Medicurés business is generating revenue to support operations and to make selected investments in the clinical advancement of AGGRASTAT.TodayMedicurés core focus is on the US commercial sales of its FDA approved small molecule, AGGRASTAT.